DMR Logo.png
Antibiotics Market Is Expected To Reach A Revenue Of USD 89.2 Bn By 2033, At 4.7 % CAGR: Dimension Market Research
22 mai 2024 12h37 HE | Dimension Market Research
New York, May 22, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global Antibiotics Market size is expected to reach USD 59.1 billion by 2024 and is further anticipated to reach USD 89.2...
factMR-logo.png
Antibacterial Drugs Market to Reach US$ 62 Billion by 2031 | Fact.MR Report
22 juin 2023 19h00 HE | FACT.MR
Rockville , June 22, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, the antibacterial drugs market is expected to witness a CAGR of 2.6% during...
logo 600X600.png
Global Antibacterial Drugs Market to Surpass US$ 65,444.5 Million by 2030, Says Coherent Market Insights (CMI)
22 août 2022 09h10 HE | CMI
Seattle, Aug. 22, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global antibacterial drugs market is estimated to be valued at US$ 44,612.2 million in 2022 and is expected to...
visiongain Logo.png
Antibacterial Drugs Market Report Up to 2031: Visiongain Research Inc
28 févr. 2022 11h00 HE | Visiongain Ltd
Visiongain has published a new report on Antibacterial Drugs Market Report 2021-2031: Forecasts By Drug Class(B-lactam, Cephalosporin, Quinolones, Carbapenems, Penicillin, Macrolides,...
Transparency Market Research.jpg
Antibacterial Drugs Market is anticipated to rise at a CAGR of 1.5% by 2025, globally: Transparency Market Research
16 janv. 2018 07h42 HE | Transparency Market Research
Albany, NY, Jan. 16, 2018 (GLOBE NEWSWIRE) -- The global antibacterial drugs market stood at US$45,325.0 million in 2016 and is projected to reach a valuation of US$51,447.6 million by the end of...
Transparency Market Research
Patent Expiries to Restrict Growth of Global Antibacterial Drugs Market to a Mere 1.30% CAGR from 2015-2023: Transparency Market Research
20 oct. 2015 15h49 HE | Transparency Market Research
Albany - NY, Oct. 20, 2015 (GLOBE NEWSWIRE) -- Rise in drug resistant species, launch of generics, and upcoming patent expirations during the period of 2015 to 2023 is likely to hamper the growth of...